| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.0008 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.001 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |